181 |
Metallic Biodegradeable Stent |
Ron Waksman |
May. 26. 06 |
180 |
Current Data Indicates No Clinically Relevant Differences Between CYPHER and TAXUS! |
Eberhard Grube |
May. 26. 06 |
179 |
The Preponderance of Data Favors CYPHER! |
David R. Holmes |
May. 26. 06 |
178 |
Countdown to COMBAT |
Roxana Mehran |
May. 26. 06 |
177 |
A Futuristic Vision of Next Generation Intravascular Ultrasound Imaging Systems |
Gary S. Mintz |
May. 26. 06 |
176 |
ENDEAVOR-III: 1 Year Results |
David E. Kandzari |
May. 19. 06 |
175 |
Technical Aspects and an Update on the EU and US ZOMAXX Clinical Trials |
Alan C. Yeung |
May. 19. 06 |
174 |
DES in the Treatment of SVG |
J.Eduardo M.R. Sousa |
May. 19. 06 |
173 |
Bioabsorbable Stents |
Jacques J. Koolen |
May. 19. 06 |
172 |
SISR. A Prospective Randomized Comparison of the Sirolimus-Eluting Stent vs Brachytherapy in Patients with Bare Metal In-Stent Restenosis |
David R. Holmes |
May. 19. 06 |